Alpha Cognition Inc (ACOG): Sotuvga nisbatan narx
Alpha Cognition rahbariyati Altsgeymer kasalligi terapiyalarini ishlab chiqishga e'tibor qaratgan, bu esa joriy GURU.Markets platformasi grafigidagi P/S tebranishlarida aks etgan bo'lib, u yerda 9.30 qiymati bazaviy ko'rsatkich vazifasini o'taydi. Kompaniya akademik erkinlik va aksiyalar opsionlari orqali bioximiklarni jalb qilmoqda, uning ekologik strategiyasi esa laboratoriya xavfsizligi va raqamlashtirishga tayanib, kelajakdagi tibbiy yutuqlar uchun asos yaratmoqda.
Alpha Cognition (ACOG) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Alpha Cognition|ACOG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati alphacognition.com|ACOG - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Alpha Cognition Corp|ACOG - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Alpha Cognition|Shoshilinch likvidlik koeffitsiyenti alphacognition.com
- foyda va bozor multiplikatorlari tafsilotlari:
ACOG - Sof foyda|Prognoz qilingan kelajakdagi foyda Alpha Cognition|ACOG - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati alphacognition.com|ACOG - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Alpha Cognition Corp|ACOG - EBITDA operatsion foydasi|Sirpanuvchi yil uchun bir aksiya uchun sof foyda Alpha Cognition|ACOG - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi alphacognition.com|ACOG - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Alpha Cognition
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ACOG, Alpha Cognition Inc
Alzheimer dori vositalari uchun o'lchov asboblarini modernizatsiya qilish va klinik sinovlarga investitsiya kirituvchi Alpha Cognition (ACOG) uchun kompaniyaning P/S koeffitsiyentini monitoring qilish biznesning bozor qiymatini uning yillik savdolariga nisbatan baholash imkonini beradi. Grafikda aks etgan ushbu koeffitsient bozor kapitalizatsiyasini daromad bilan solishtiradi, bu esa investorlarga joriy qiymatlarni tarixiy tendentsiya bilan qiyoslagan holda aktivlarning haddan tashqari qimmat baholanganini aniqlash yoki emitentning yetakchiligini tasdiqlashga yordam beradi.
Alpha Cognition raqobatchilari
Kapitalizatsiyaning daromadga nisbati biogen.com BIIB|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|Axsome Therapeutics Inc - P/S multiplikatori|Narx/daromad multiplikatori ACADIA Corp (ACAD)|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati VKTX|SUPN (Supernus) - P/S multiplikatori|Catalyst Pharma (CPRX) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|Kapitalizatsiyaning sotish hajmiga nisbati HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|Narx/daromad koeffitsiyenti amylyx.com (AMLX)|TRVI - Narxning daromadga nisbati|Sotuvga nisbatan narx Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati CBLL|PRTA (Prothena Biosciences) - P/S multiplikatori|P/S multiplikatori Alector Therapeutics|P/S multiplikatori ANNX|Kapitalizatsiyaning daromadga nisbati omeros.com OMER|Narxning daromadga nisbati Neurogene Corp NGNE|AC Immune Inc (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics - P/S multiplikatori|Narx/daromad multiplikatori neumoratx.com (NMRA)|Scilex (SCLX) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati TVGN|CGTX (Cognition Therapeutics, Inc.) - P/S multiplikatori|Sotuvga nisbatan narx Inhibikase Pharma IKT|Kapitalizatsiyaning daromadga nisbati SAVA (Cassava Sciences, Inc.)|P/S multiplikatori assertiotx.com (ASRT)|Narxning daromadga nisbati Coya Therapeutics COYA|Bozor kapitallashuvining daromadga nisbati VTGN|OVID - Narxning daromadga nisbati|Sotuvga nisbatan narx Acumen Pharmaceuticals, Inc|CRVO: P/S multiplikatori|Alterity Therapeutics Limited (ATHE) - P/S multiplikatori|Narxning daromadga nisbati Clene Inc|Narxning daromadga nisbati PEPG|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|RLMD: Narxning sotuvga nisbati|P/S multiplikatori ANVS (Annovis Bio, Inc.)|Bozor kapitallashuvining daromadga nisbati GRCE|Firefly Neuroscience - P/S multiplikatori|KLTO - P/S multiplikatori|NRSN (neurosense-tx.com) - Kapitalizatsiyaning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|MTVA (MetaVia Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati neuraxis.com (NRXS)|Narxning daromadga nisbati Helius Medical (HSDT)|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|Narx/daromad multiplikatori Minerva|ATHA - Narxning daromadga nisbati|ADXN (addextherapeutics.com) - Kapitalizatsiya va daromad nisbati|ALZN: P/S multiplikatori|CYCN - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA (Pasithea) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori CRGT|Narx/daromad koeffitsiyenti avenuetx.com|Narxning daromadga nisbati BrainStorm Cell Therapeutics BCLI|Cara Therapeutics Inc. (CARA) - Sotuvga nisbatan narx|CHRO - Narxning daromadga nisbati|ELYM (Eliem Therapeutics) - Kapitalizatsiya va daromad nisbati|ITCI: P/S multiplikatori|longboardpharma.com (LBPH) - P/S multiplikatori|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati NKGen Biotech Inc (NKGN)|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE - Sotuvga nisbatan narx|P/S multiplikatori SNPX (Synaptogenix, Inc.)|Narx/daromad multiplikatori trevena.com|VIGL - Narxning daromadga nisbati|WENA (anewmeds.com) - Kapitalizatsiya va daromad nisbati|CERE: P/S multiplikatori
